Dean M Wingerchuk Selected Research

Immunoglobulin G (IgG)

3/2022	Network Meta-analysis of Food and Drug Administration-approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder.
1/2022	Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension.
1/2022	Frequency of Asymptomatic Optic Nerve Enhancement in a Large Retrospective Cohort of Patients With Aquaporin-4+ NMOSD.
10/2021	Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders.
5/2021	Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension.
2/2021	Interleukin-6 inhibition with tocilizumab for relapsing MOG-IgG associated disorder (MOGAD): A case-series and review.
1/2021	Serum Neurofilament to Magnetic Resonance Imaging Lesion Area Ratio Differentiates Spinal Cord Infarction From Acute Myelitis.
1/2021	Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD.
12/2020	Application of 2015 Seronegative Neuromyelitis Optica Spectrum Disorder Diagnostic Criteria for Patients With Myelin Oligodendrocyte Glycoprotein IgG-Associated Disorders.
1/2019	Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dean M Wingerchuk Research Topics

Disease

46	Neuromyelitis Optica (Devic's Disease) 03/2022 - 03/2003
30	Multiple Sclerosis 02/2021 - 04/2002
11	Myelitis 01/2021 - 05/2005
11	Optic Neuritis (Retrobulbar Neuritis) 11/2018 - 05/2005
10	Stroke (Strokes) 05/2021 - 01/2008
9	Transverse Myelitis (Necrotizing Myelitis) 01/2021 - 01/2006
8	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 06/2007
7	Ischemic Stroke 05/2021 - 01/2008
6	Epilepsy (Aura) 05/2018 - 09/2010
4	Infections 01/2021 - 03/2011
4	Seizures (Absence Seizure) 05/2018 - 12/2004
3	Headache (Headaches) 05/2021 - 09/2011
3	Spinal Cord Diseases 01/2021 - 01/2017
3	Migraine Disorders (Migraine) 07/2020 - 10/2008
3	Cerebral Hemorrhage 01/2019 - 07/2011
3	Dementia (Dementias) 01/2017 - 07/2009
3	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 04/2006
3	Cognitive Dysfunction 01/2012 - 01/2007
3	Necrosis 09/2007 - 06/2007
2	Brain Neoplasms (Brain Tumor) 09/2022 - 12/2004
2	Respiratory Tract Infections (Respiratory Tract Infection) 05/2021 - 01/2019
2	Infarction (Infarctions) 01/2021 - 11/2011
2	Headache Disorders (Headache Syndromes) 07/2020 - 09/2011
2	Aneurysm (Aneurysms) 09/2018 - 11/2010
2	Partial Epilepsies (Epilepsy, Partial) 05/2018 - 01/2007
2	Disease Progression 01/2018 - 04/2002
2	Neoplasms (Cancer) 01/2018 - 12/2004
2	Hemorrhage 07/2017 - 11/2010
2	Myasthenia Gravis 05/2015 - 01/2009
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2015 - 05/2012
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2011 - 01/2011
2	Alzheimer Disease (Alzheimer's Disease) 03/2011 - 07/2009
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 11/2010 - 11/2008
1	Melanoma (Melanoma, Malignant) 09/2022
1	Conversion Disorder (Astasia Abasia) 01/2022
1	Lymphoma (Lymphomas) 07/2021
1	Bone Fractures (Bone Fracture) 05/2021
1	Nasopharyngitis 05/2021
1	Eye Pain 02/2021
1	Pain (Aches) 07/2020
1	COVID-19 07/2020

Drug/Important Bio-Agent (IBA)

34	Immunoglobulin G (IgG)IBA 03/2022 - 12/2004
17	AutoantibodiesIBA 01/2018 - 12/2004
10	Aquaporin 4IBA 10/2021 - 07/2006
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2006
7	Aquaporins (Water Channels)IBA 05/2021 - 06/2007
7	Rituximab (Mabthera)FDA Link 01/2021 - 11/2008
6	eculizumab FDA Link 01/2022 - 06/2013
6	Myelin-Oligodendrocyte GlycoproteinIBA 02/2021 - 11/2018
6	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2021 - 05/2005
6	Complement System Proteins (Complement)IBA 01/2021 - 01/2007
6	AntibodiesIBA 01/2021 - 06/2007
5	Anticonvulsants (Antiepileptic Drugs)IBA 02/2015 - 12/2004
4	Immunoglobulins (Immunoglobulin)IBA 01/2013 - 04/2006
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2019 - 11/2011
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2018 - 09/2009
3	AntigensIBA 01/2017 - 08/2013
3	Glatiramer Acetate (Copaxone)FDA Link 01/2016 - 03/2006
3	Intravenous Immunoglobulins (IVIG)FDA Link 05/2015 - 01/2013
3	Interferon-betaIBA 02/2014 - 03/2006
3	Donepezil (Aricept)FDA LinkGeneric 01/2012 - 01/2007
2	inebilizumabIBA 01/2022 - 10/2019
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2021 - 01/2013
2	tocilizumab (atlizumab)FDA Link 02/2021 - 07/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 07/2020 - 02/2014
2	Pharmaceutical PreparationsIBA 07/2020 - 09/2010
2	Azathioprine (Imuran)FDA LinkGeneric 03/2014 - 01/2014
2	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2014 - 03/2006
2	Neutralizing AntibodiesIBA 02/2014 - 05/2010
2	InterferonsIBA 10/2012 - 05/2010
2	Antinuclear AntibodiesIBA 01/2012 - 01/2008
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2012 - 01/2007
2	Vitamin D FDA LinkGeneric 03/2011 - 06/2010
2	Memantine (Namenda)FDA Link 03/2011 - 01/2007
2	Topiramate (Topamax)FDA LinkGeneric 09/2010 - 01/2007
2	Lamotrigine (Lamictal)FDA LinkGeneric 09/2010 - 01/2007
2	Gabapentin (Neurontin)FDA LinkGeneric 09/2010 - 01/2007
2	Valproic Acid (Depakote)FDA LinkGeneric 09/2010 - 12/2004
2	Oxcarbazepine (Trileptal)FDA LinkGeneric 09/2010 - 01/2007
2	Tiagabine (Gabitril)FDA Link 09/2010 - 01/2007
2	Rivastigmine (Exelon)FDA LinkGeneric 07/2009 - 01/2007
1	NivolumabIBA 09/2022
1	IpilimumabIBA 09/2022
1	Immune Checkpoint InhibitorsIBA 09/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 05/2021
1	Complement Inactivating AgentsIBA 05/2021
1	salicylhydroxamic acid (SHAM)IBA 07/2020

Therapy/Procedure

29	Therapeutics 09/2022 - 04/2002
6	Immunotherapy 01/2021 - 01/2014
3	Plasmapheresis 01/2008 - 05/2005
2	Drug Therapy (Chemotherapy) 07/2021 - 09/2011
2	Thrombectomy 03/2021 - 01/2019
2	Aftercare (After-Treatment) 07/2020 - 05/2015
2	Secondary Prevention 05/2005 - 03/2003
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Radiotherapy 07/2021
1	Stem Cell Transplantation 07/2021
1	General Anesthesia 03/2021
1	Conscious Sedation 03/2021
1	Vagus Nerve Stimulation 07/2020